… When we tested RP101 as an anti-cancer drug in a rat model… , DNA repair, and recombination.
It regulates apoptosis through … “recovery” treatment in the phase 2 study: In this study, one …

… These features make it a rational anticancer therapy; … and antiviral activity, whereas type II
IFN-γ has weaker antiviral … Two phase II studies have demonstrated that although sorafenib (…

… We demonstrate that this combination induces potent antitumor … A phase II trial investigating
the ability of MUC1 vaccine to … evaluated the safety and immunogenicity of a recombinant …

… as they can lead to reduction of antitumor cytotoxicity of T cells and … CT26 colorectal carcinoma,
monotherapy with anti-TIGIT therapy … have been tested as antiviral treatments, and now …

… inhibition would enhance the antitumor effects of radiation … (stage II or III) rectal cancer were
identified from published … tumor size to receive placebo, radiotherapy (6 Gy × 2), epacadostat …

… in the clinical development of recombinant/purified TAAs or … TLR3 ligand in 46 advanced
colorectal carcinoma patients. In this … NCT00841399 (a Phase I-II study) investigated the clinical …

… ), a recombinant adenovirus, is approved for the treatment of … with other anticancer agents;
therefore, OV therapy lends itself … antiviral immune response of the patient. The most effective …

… functions of anticancer, anti-inflammatory, antioxidant, antiviral and … effects in metastatic
colorectal cancer (86). Clinical … phase II study demonstrated that Cinobufacin injection, when …

… In a phase II study of combination therapy of IT HF10 and … , because of the defective antiviral
mechanisms in malignant cells … in the injected tumor microenvironment leading to anti-tumor …

… In a phase II clinical trial, 37 recurrent HNSCC patients … cells, resulting in heightened antitumor
effectiveness in vitro and … However, upon entry into the body, the host’s antiviral defense …